Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTocilizumab is safe and tolerable and reduces C‐reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients.AuthorsMilligan, Carol; Atassi, Nazem; Babu, Suma; Barohn, Richard J.; Caress, James B.; Cudkowicz, Merit E.; Evora, Armineuza; Hawkins, Gregory A.; Wosiski‐Kuhn, Marlena; Macklin, Eric A.; Shefner, Jeremy M.; Simmons, Zachary; Bowser, Robert P.; Ladha, Shafeeq S.PublicationMuscle & Nerve, 2021, Vol 64, Issue 3, p309ISSN0148-639XPublication typeArticleDOI10.1002/mus.27339